Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 14, 2016; 22(46): 10232-10241
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10232
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10232
Table 2 Risk factors for prognosis of patients (n = 65)
| Variable | Univariate analysis | Multivariate analysis | ||||
| Hazard ratio | 95%CI | P value | Hazard ratio | 95%CI | P value | |
| Number of high telomerase activity cells | ||||||
| ≤ 5 | 1.0 | 1.0 | ||||
| > 5 | 2.069 | 0.693-5.744 | 0.183 | 0.900 | 0.294-2.591 | 0.847 |
| fStage | ||||||
| fStage I | 1.0 | 1.0 | ||||
| fStage II | 7.097 | 0.281-179.3 | 0.196 | 7.106 | 0.281-179.6 | 0.182 |
| fStage III | 25.18 | 4.053-482.6 | 0.0003b | 26.17 | 4.017-510.6 | 0.0004b |
| fStage IV | 83.57 | 14.86-1567 | < 0.0001b | 85.76 | 14.91-1623 | < 0.0001b |
- Citation: Ito H, Sato J, Tsujino Y, Yamaguchi N, Kimura S, Gohda K, Murakami K, Onimaru M, Ohmori T, Ishikawa F, Inoue H. Long-term prognostic impact of circulating tumour cells in gastric cancer patients. World J Gastroenterol 2016; 22(46): 10232-10241
- URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10232.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i46.10232